Human Growth Hormone (HGH, somatotropin) is a 191-amino acid peptide hormone produced by the anterior pituitary gland. It is the primary hormone regulating growth, body composition, cell repair, and metabolism. Synthetic recombinant HGH (rhGH) is bioidentical to endogenous growth hormone and is FDA-approved for growth hormone deficiency, Turner syndrome, and other conditions. In the performance and anti-aging context, exogenous HGH is used for fat loss, lean mass preservation, improved recovery, enhanced skin and hair quality, improved sleep, and overall anti-aging benefits. Natural HGH production declines approximately 14% per decade after age 30, driving interest in replacement.
Notes
Pharmaceutical-grade recombinant HGH is FDA-approved for several conditions. Off-label use for anti-aging and performance is common but exists in a legal gray area. Quality and purity of non-pharmaceutical sources vary significantly. Always verify with a serum GH or IGF-1 test after starting to confirm the product is genuine.
HGH binds to growth hormone receptors (GHR) on target cells, primarily in the liver, triggering the JAK-STAT signaling cascade. This stimulates hepatic production of Insulin-like Growth Factor 1 (IGF-1), which mediates many of HGH's anabolic and growth-promoting effects. Direct effects of HGH include: lipolysis (mobilization of stored fat for energy), increased protein synthesis, enhanced amino acid transport, stimulation of gluconeogenesis, and anti-insulin effects on glucose metabolism. IGF-1-mediated effects include: cell proliferation and hyperplasia, cartilage and bone growth, collagen synthesis, and organ growth. HGH also stimulates immune function and thymic activity.
Subcutaneous injection produces peak plasma levels in 2-6 hours. Bioavailability is approximately 75% subcutaneously. HGH is cleared from plasma with a half-life of 3-5 hours, but its effects persist much longer because the liver continues to produce IGF-1 for 12-20 hours after each HGH pulse. IGF-1 has a longer half-life (15-20 hours) due to binding with IGF binding proteins (IGFBPs). HGH is metabolized primarily in the liver and kidneys. Endogenous HGH is released in pulsatile fashion, with the largest pulse occurring during deep sleep (stage 3-4 NREM).
Typical Dose
Anti-aging/wellness: 1-2 IU per day. Fat loss: 2-4 IU per day. Bodybuilding/performance: 4-8 IU per day. Clinical replacement: dose titrated to normalize IGF-1 levels. Beginners should start at 1-2 IU and increase gradually over weeks.
Frequency
Once daily (single injection in the morning or before bed) or split into AM/PM doses at higher amounts. For fat loss, fasted morning injection is popular. For recovery and sleep, evening dosing is preferred. Doses above 4 IU are commonly split.
Administration
Subcutaneous injection (preferred for performance/anti-aging use) or intramuscular injection. Subcutaneous is absorbed more slowly, producing a more sustained elevation. Inject in the abdominal subcutaneous fat for best absorption. Rotate sites.
Half-Life
3-5 hours (plasma half-life); biological effects of each pulse last 9-17 hours via IGF-1 signaling
Contraindications
No PCT required for HGH itself. HGH does not suppress testosterone or the HPTA. However, if stacking HGH with anabolic compounds, PCT for those compounds is still necessary. After discontinuing HGH, the body's natural GH production resumes, though it may take a few weeks for pituitary function to normalize. There is no evidence of permanent pituitary suppression from exogenous HGH use.